Holen Sie sich die Stockscreener-App
2.32
2.47%
0.09
Schlusskurs vom Vortag:
$2.23
Offen:
$2.2
24-Stunden-Volumen:
49,616
Relative Volume:
1.11
Marktkapitalisierung:
$8.49M
Einnahmen:
$6,000
Nettoeinkommen (Verlust:
$-6.00M
KGV:
-1.0111
EPS:
-2.2945
Netto-Cashflow:
$-5.86M
1W Leistung:
+2.93%
1M Leistung:
+6.78%
6M Leistung:
-23.06%
1J Leistung:
+15.40%
1-Tages-Spanne:
$2.20
$2.325
1-Wochen-Bereich:
$2.15
$2.32
52-Wochen-Spanne:
$1.504
$6.25
Creative Medical Technology Holdings Inc Stock (CELZ) Company Profile
Firmenname
Creative Medical Technology Holdings Inc
Sektor
Branche
Telefon
480-399-2822
Adresse
211 E. OSBORN RD., PHOENIX
Compare CELZ vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CELZ
Creative Medical Technology Holdings Inc
|
2.2955 | 8.24M | 6,000 | -6.00M | -5.86M | -2.2945 |
VRTX
Vertex Pharmaceuticals Inc
|
428.60 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
718.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
811.52 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
304.15 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
312.07 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Creative Medical Technology Holdings Inc Aktie (CELZ) Neueste Nachrichten
BZLEY Should I Buy - Intellectia AI
Creative Medical (CELZ) Reports Encouraging Pilot Study Results for Ultrasome Therapy - GuruFocus
Creative Medical (CELZ) Reports Promising Osteoarthritis Therapy Results - GuruFocus
BY Technical Analysis & Price Forecast - Intellectia AI
Creative Medical reports positive pilot study results for Ultrasome - Investing.com UK
Creative Medical reports positive pilot study results for Ultrasome By Investing.com - Investing.com Canada
Park Place Technologies Partners with Professional Athlete Genie Bouchard as 'Genie from IT” in New TV Commercial - The Manila Times
Uncertainty Around AI’s Impact on Careers Clouds Students’ College Decisions - The Manila Times
Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapies - marketscreener.com
Cell-free knee arthritis therapy posts 93% response in pilot study - Stock Titan
JXHLY Forecast — Price Prediction for 2026. Should I Buy JXHLY? - Intellectia AI
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
NPSKY Technical Analysis & Stock Price Forecast - Intellectia AI
BHPCD Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Iran Hormuz Strait Crisis: Oil Market Impact & Energy Investment Strategy 2026 - Intellectia AI
NAII Technical Analysis & Price Forecast - Intellectia AI
MITT Technical Analysis & Price Forecast - Intellectia AI
RWAY Technical Analysis & Price Forecast - Intellectia AI
Creative Medical Technology Holdings, Inc. 2025 Annual Report: Executive Summary, Compensation, and Compliance Disclosures - Minichart
IBEX Technical Analysis & Price Forecast - Intellectia AI
TOVXPrice, Charts & Blockchain Insights - Intellectia AI
Creative Medical (NASDAQ: CELZ) details 2025 pay, ownership and deals - Stock Titan
VMC Technical Analysis & Price Forecast - Intellectia AI
GE Vernova Stock Analysis 2026: Q1 Earnings Beat Signals Powerhouse Momentum - Intellectia AI
HDSN Technical Analysis & Price Forecast - Intellectia AI
CreativeMed (CELZ) Volatility Analysis | Q3 2025: Profit SurprisesBest Pick - Cổng thông tin điện tử tỉnh Lào Cai
PVH Technical Analysis & Price Forecast - Intellectia AI
VIVK Technical Analysis & Price Forecast - Intellectia AI
Form 10-KAnnual report [Section 13 and 15(d), not S-K Item 405] - ADVFN
CreativeMed (CELZ) Stock Moving VWAP (Advances) 2026-04-18Open Stock Signal Network - Newser
$ADA PE Ratio & Valuation, Is $ADA Overvalued - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
Breakout Zone: Can Creative Medical Technology Holdings Inc continue delivering strong returns2026 Sentiment & Capital Efficient Trading Techniques - baoquankhu1.vn
Growth Review: What is the earnings history of Creative Medical Technology Holdings IncQuarterly Trade Report & Detailed Earnings Play Strategies - baoquankhu1.vn
Street Watch: Does AVPTW have a sustainable dividendPortfolio Risk Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Aug Opening: Is Sky Harbour Group Corporation being accumulated by smart money2026 Earnings Impact & Stepwise Trade Signal Guides - baoquankhu1.vn
CREATIVE MEDICAL TECHNOLOGY HOLDINGS Operating Margin %: -64 - GuruFocus
Income Plays: Is Creative Medical Technology Holdings Inc forming bullish engulfing patternsIndex Update & AI Based Buy/Sell Signal Reports - baoquankhu1.vn
Aug Weekly: Is Starwood Property Trust Inc a top pick in the sectorLayoff News & Stepwise Trade Execution Plans - baoquankhu1.vn
New Highs: What is ACCOs market positionPortfolio Update Summary & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Analysts Expect Breakeven For Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Before Long - Yahoo Finance
Leading Companies Enhancing Their Presence in the Cancer Anorexia-Cachexia Syndrome (CACS) Market - openPR.com
TKWY-NL PE Ratio & Valuation, Is TKWY-NL Overvalued - Intellectia AI
What are analysts price targets for Royal Caribbean Cruises LtdEntry Point & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Alphabet, Inc. | History, Products, & Business Segments - Britannica
KPET Ultra Paceline Corp 2026 Audited Balance Sheet and Financial Statement Highlights - Minichart
NVNO PE Ratio & Valuation, Is NVNO Overvalued - Intellectia AI
NXL PE Ratio & Valuation, Is NXL Overvalued - Intellectia AI
CELZ (Creative Medical Technology Holdings) Policyholder Fu - GuruFocus
When Will Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Become Profitable? - Sahm
Clean Energy Technologies, Inc. (CETY) Stock Price, News, Quote & History - Yahoo! Finance Canada
Finanzdaten der Creative Medical Technology Holdings Inc-Aktie (CELZ)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.78%
3.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):